首页 | 本学科首页   官方微博 | 高级检索  
     

2种舒他西林片的人体生物等效性
引用本文:郑鹏程,李铜铃,许小红,杨岚,黄婷,陈束叶,程强. 2种舒他西林片的人体生物等效性[J]. 中国新药与临床杂志, 2006, 25(5): 346-349
作者姓名:郑鹏程  李铜铃  许小红  杨岚  黄婷  陈束叶  程强
作者单位:1. 云南省第一人民医院,药剂科,云南,昆明,650032
2. 四川大学华西药学院,临床药学教研室,四川,成都,610041
摘    要:目的:比较口服2种舒他西林片的相对生物利用度。方法:20名健康男性受试者采用随机交叉试验设计。反相高效液相色谱法测定单剂量口服2种舒他西林片750 mg后的氨苄西林、舒巴坦血药浓度。DAS程序计算药动学参数,AUC,c_(max)对数转换后进行分析。结果:口服舒他西林受试制剂和参比制剂氨苄西林的c_(max)分别是(10.8±s 1.9),(10.4±1.8)mg·L~(-1);t_(max)分别是(0.68±0.14),(0.66±0.12)h;AUC_(0-t)分别为(22±4),(22±4)mg·h·L~(-1);AUC_(0-∞)分别为(24±5),(23±4)mg·h·L~(-1);t_(1/2)分别是(1.07±0.26),(1.13±0.25)h。口服舒他西林受试制剂和参比制剂舒巴坦的c_(max)分别是(7.4±1.3),(7.3±1.2)mg·L~(-1),t_(max)分别是(0.66±0.12),(0.70±0.10)h,AUC_(0-t)分别为(13.7±2.8),(13.2±2.3)mg·h·L~(-1);AUC_(0-∞)分别为(14.2±2.9),(13.7±2.5)mg·h·L~(-1);t_(1/2)分别是(0.97±0.19),(0.87±0.24)h。结论:2种舒他西林片具有生物等效性。

关 键 词:抗感染药  舒他西林  片剂  色谱法,高压液相  生物利用度
文章编号:1007-7669(2006)05-0346-04
收稿时间:2005-06-23
修稿时间:2005-06-232006-03-20

Bioequivalence study of two formulations of domestic sultamicillin in healthy volunteers
ZHENG Peng-cheng,LI Tong-ling,XU Xiao-hong,YANG Lan,HUANG Ting,CHEN Shu-ye,CHENG Qiang. Bioequivalence study of two formulations of domestic sultamicillin in healthy volunteers[J]. Chinese Journal of New Drugs and Clinical Remedies, 2006, 25(5): 346-349
Authors:ZHENG Peng-cheng  LI Tong-ling  XU Xiao-hong  YANG Lan  HUANG Ting  CHEN Shu-ye  CHENG Qiang
Abstract:AIM:To evaluate the bioavailability of sultamicillin tablets from two companies.METHODS: Randomized,cross over designed trial conducted in 20 healthy volunteers.The plasma concentration of ampicillin and sulbactam were tested by reversed-phase high pressure liquid chromatography after a single oral dose of 750 mg tablets of study drug or reference drug.The pharmacokinetic parameters were calculated by pharmaceutic software named DAS.AUC and c_(max)were analyzed after logarithmic transform.RESULTS:The pharmacokinetic parameters of study drug vs reference drug were as follows:ampieillin c_(max),(10.8±s 1.9)mg·L~(-1) and(10.4±1.8)mg·L~(-1);t_(max), (0.68±0.14)h and (0.66±0.12)h;AUC_(0-t),(22±4)mg·h·L~(-1) and(22±4)mg·h·L~(-1);AUC_(0-∞),(24±5)mg·h·L~(-1)and(23±4)mg·h·L~(-1);t_(1/2),(1.07±0.26)h and(1.13±0.25)h;sulbactam c_(max),(7.4±1.3)mg·L~(-1) and (7.3±1.2)mg·L~(-1);t_(max),(0.66±0.12)h and(0.70±0.10)h;AUC_(0-t),(13.7±2.8)mg·h·L~(-1) and(13.2±2.3)mg·h·L~(-1);AUC_(0-∞),(14.2±2.9)mg·h·L~(-1)and(13.7±2.5)mg·h·L~(-1);t_(1/2),(0.97±0.19)h and(0.87±0.24)h. CONCLUSION:The two formulations of sultamicillin tablets are bioequivalent.
Keywords:anti-infective agents    sultamicillin    tablets    chromatography,high pressure liquid    biological availability
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号